Leggett & Platt (NYSE: LEG) posts weaker Q1 2026 results amid pending Somnigroup merger
Rhea-AI Filing Summary
Leggett & Platt reported weaker first-quarter 2026 results as end-market demand softened and costs rose. Trade sales were $918.2 million, down 10% from $1,022.1 million a year earlier, with volume at same locations down 9%.
EBIT fell to $44.5 million from $62.9 million, and net earnings declined to $20.0 million versus $30.6 million. Diluted EPS decreased to $0.14 from $0.22, while adjusted EPS was $0.15, down from $0.24. Adjusted EBIT dropped to $43.4 million from $66.6 million, and adjusted EBITDA to $71.6 million from $98.2 million.
Operating cash flow swung to an outflow of $56.1 million compared with an inflow of $6.8 million in the prior-year quarter, driven by a larger working-capital build. Management cited weak U.S. bedding demand, macro uncertainty, and cost pressures, including impacts from the war in Iran. The company highlighted a previously signed merger agreement with Somnigroup International Inc., expected to close by year-end 2026 subject to shareholder and regulatory approvals, and withdrew prior 2026 guidance, stating it should no longer be relied upon.
Positive
- None.
Negative
- Material deterioration in earnings and cash flow: Q1 2026 trade sales declined 10%, EBIT fell 29%, EPS dropped 36%, and operating cash flow swung to a $56.1 million outflow, signaling pressure on profitability and near-term liquidity.
Insights
Q1 2026 shows broad profit pressure, cash outflow and deal overhang.
Leggett & Platt delivered a challenging quarter. Trade sales fell 10% to $918.2 million, with net earnings down to $20.0 million and EPS at $0.14. Profitability compressed as EBIT dropped 29% to $44.5 million, and adjusted EBITDA declined to $71.6 million from $98.2 million.
Cash generation weakened meaningfully. Net cash from operating activities was $(56.1) million versus $6.8 million a year earlier, mainly from a larger working-capital increase. While total assets and equity were stable as of March 31, 2026, the net debt to trailing 12‑month adjusted EBITDA ratio rose to 2.75x from 2.36x at year-end 2025.
Strategically, the company is moving toward a merger with Somnigroup International Inc., expected by year-end 2026 subject to approvals. As is typical during pending transactions, prior 2026 guidance has been withdrawn and no conference call will be held, so investors will need to rely on this and future statutory filings for updates.
8-K Event Classification
Key Figures
Key Terms
Adjusted EBITDA financial
Organic Sales financial
Net Debt / 12-month Adjusted EBITDA financial
Somnigroup Merger financial
forward-looking statements regulatory
Earnings Snapshot
Previously issued 2026 guidance is not being updated and should no longer be relied upon while the Somnigroup merger, expected to close by year-end 2026, is pending.